{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T18:06:55Z","timestamp":1784311615417,"version":"3.55.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":2653,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1038\/ki.2008.59","type":"journal-article","created":{"date-parts":[[2008,3,12]],"date-time":"2008-03-12T20:39:42Z","timestamp":1205354382000},"page":"679-683","source":"Crossref","is-referenced-by-count":27,"title":["Managing anemia in dialysis patients: hemoglobin cycling and overshoot"],"prefix":"10.1016","volume":"74","author":[{"given":"Ajay K.","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Milford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Fishbane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Ram","family":"Keithi-Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2008.59_bb0010","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJM199808273390903","article-title":"The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin","volume":"339","author":"Besarab","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2008.59_bb0015","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/j.1523-1755.2005.00532.x","article-title":"Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin","volume":"68","author":"Fishbane","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.59_bb0020","series-title":"FDA strengthens safety information for erythropoiesis-stimulating agents (ESAs)","author":"FDA","year":"2007"},{"key":"10.1038\/ki.2008.59_bb0025","first-page":"55","article-title":"The FDA Black Box for EPO: what should nephrologists do?","volume":"21","author":"Singh","year":"2007","journal-title":"Nephrol News Issues"},{"key":"10.1038\/ki.2008.59_bb0030","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa065485","article-title":"Correction of anemia with epoetin alfa in chronic kidney disease","volume":"355","author":"Singh","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2008.59_bb0035","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa062276","article-title":"Normalization of hemoglobin level in patients with chronic kidney disease and anemia","volume":"355","author":"Drueke","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2008.59_bb0040","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0140-6736(07)60194-9","article-title":"Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis","volume":"369","author":"Phrommintikul","year":"2007","journal-title":"Lancet"},{"key":"10.1038\/ki.2008.59_bb0045","author":"FDA"},{"key":"10.1038\/ki.2008.59_bb0050","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2004121039","article-title":"Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease","volume":"16","author":"Parfrey","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.59_bb0055","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1525-139X.2006.00165.x","article-title":"Hemoglobin variability: random fluctuation, epiphenomenon, or phenomenon?","volume":"19","author":"Berns","year":"2006","journal-title":"Semin Dial"},{"key":"10.1038\/ki.2008.59_bb0060","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/ajkd.2003.50030","article-title":"Effect of variability in anemia management on hemoglobin outcomes in ESRD","volume":"41","author":"Lacson","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2008.59_bb0065","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.ajkd.2005.05.018","article-title":"Epoetin alfa use in patients with ESRD: an analysis of recent US prescribing patterns and hemoglobin outcomes","volume":"46","author":"Collins","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2008.59_bb0070","series-title":"US Renal Data System Annual Data Report, Atlas of End Stage Renal Disease in the United States","author":"USRDS","year":"2006"},{"key":"10.1038\/ki.2008.59_bb0075","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1159\/000046281","article-title":"Erythropoietin requirements increase following hospitalization in end-stage renal disease patients","volume":"21","author":"Yaqub","year":"2001","journal-title":"Am J Nephrol"},{"key":"10.1038\/ki.2008.59_bb0080","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2215\/CJN.01610407","article-title":"Hemoglobin level variability: associations with mortality","volume":"3","author":"Gilbertson","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.59_bb0085","first-page":"S11","article-title":"Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease","volume":"47","author":"KDOQI","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2008.59_bb0090","series-title":"National Kidney Foundation Releases Preliminary Anemia Guideline Update. New Evidence Spurs Re-examination of 2006 Recommendations","author":"K\/DOQI N","year":"2007"},{"key":"10.1038\/ki.2008.59_bb0095","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1046\/j.1523-1755.2003.00229.x","article-title":"Hemoglobin variability in epoetin-treated hemodialysis patients","volume":"64","author":"Berns","year":"2003","journal-title":"Kidney Int"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815533838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815533838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T03:25:51Z","timestamp":1546226751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815533838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0085253815533838"],"URL":"https:\/\/doi.org\/10.1038\/ki.2008.59","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}